Nucana Plc current report, Q3 FY2022

Nucana Plc Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Nucana Plc, a foreign private issuer, for the month of September 2022. The filing reports on "Other Events" occurring on September 6, 2022.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an event notification and does not contain financial statements.

Material Changes

No material financial changes versus the prior comparable period are reported in this filing.

Outlook, Commentary, and Events

  • ESMO Congress Presentations: On September 6, 2022, the Company announced it will make two presentations at the European Society for Medical Oncology (ESMO) Congress 2022.
  • Event Details: The congress is scheduled for September 9-13, 2022, at the Paris Expo Porte de Versailles in Paris, France.
  • Legal Status: The press release attached as Exhibit 99.1 is furnished but not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that Section.

Key Facts for Investor Verification

  • Verify the specific content and data of the two presentations to be delivered at the ESMO Congress 2022.
  • Confirm the date and location of the ESMO Congress (September 9-13, 2022, Paris, France).
  • Note that the attached press release is not incorporated by reference into other filings unless expressly stated.